4/A

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: January 27, 2011
Period of Report: January 14, 2009
Accession Number: 0001437749-11-000467

View Document ↗ View on SEC.gov ↗